List view / Grid view

Formulation

 

article

Solving the taxing problems of taxanes?

4 November 2022 | By

Could the new wave of taxane chemotherapies succeed where traditional chemotherapies have failed? Colin Freund, Chief Executive Officer of Modra Pharmaceuticals, reveals the benefits of this emerging generation of anticancer treatment.

article

Drug Formulation In-Depth Focus 2022

27 October 2022 | By

Articles in this drug formulation In-Depth Focus explore the design of formulations using cyclodextrins, plus the development of orally-delivered taxane chemotherapies. 

article

Elements leading to a rational design of cyclodextrin-based formulations

21 October 2022 | By

Cyclodextrins are a frequently used excipient in the pharmaceutical industry, employed in multiple dosage forms and with multiple purposes simply because of their numerous positive properties, including being generally well tolerated and safe. In this short article, René Holm, Professor in pharmaceutical physical chemistry at the University of Southern Denmark,…